Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Biogen Idec (NASDAQ:BIIB) and PDL (NASDAQ:PDLI) granted Ophthotech (Princeton, N.J.)
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury